Plerixafor in Patients with Decreased Mobilizing Ability of Autologous Hematopoietic Stem Cells

Plerixafor in Patients with Decreased Mobilizing Ability of Autologous Hematopoietic Stem Cells

Background & Aims. Autologous hematopoietic stem cell transplantation (autoHSCT) is an effective treatment for patients with malignant lymphoproliferative disorders, multiple myelomas and solid tumors sensitive to chemotherapy. Harvesting of hematopoietic stem cells (HSC) prior autoHSCT may be i...

Full description

Bibliographic Details
Main Authors: MA Kucher, МS Motalkina, ОU Klimova, ЕV Kondakova, ОB Kalashnikova, SМ Alekseev, DV Motorin, DV Babenetskaya, EI Podol’tseva, NB Mikhailova, МА Estrina, ЕV Babenko, AYu Zaritskii, BV Afanas’ev
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2016-04-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
hematopoietic stem cell mobilization
G-CSF
pegfilgrastim
plerixafor
Online Access:http://bloodjournal.ru/en/plerixafor-in-patients-with-decreased-mobilizing-ability-of-autologous-hematopoietic-stem-cells/

Internet

http://bloodjournal.ru/en/plerixafor-in-patients-with-decreased-mobilizing-ability-of-autologous-hematopoietic-stem-cells/

Similar Items